济民健康
(603222)
| 流通市值：50.20亿 | | | 总市值：50.20亿 |
| 流通股本：5.25亿 | | | 总股本：5.25亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 282,188,756.89 | 295,283,804.31 | 335,609,801.71 | 349,727,496.51 |
| 应收票据及应收账款 | 110,623,115.56 | 115,815,240.53 | 150,060,274.17 | 143,063,462.77 |
| 应收账款 | 110,623,115.56 | 115,815,240.53 | 150,060,274.17 | 143,063,462.77 |
| 应收款项融资 | 2,264,351.4 | 2,342,661.52 | 3,305,211.8 | 1,613,045.97 |
| 预付款项 | 8,250,179.25 | 3,971,974.84 | 4,382,076.52 | 6,029,711.75 |
| 其他应收款合计 | 49,622,863.85 | 53,496,646.97 | 53,126,153.57 | 53,512,844.13 |
| 存货 | 104,099,453.07 | 112,687,297.11 | 134,461,736.7 | 149,389,802.25 |
| 其他流动资产 | 1,653,384.63 | 1,693,803.72 | 2,133,073.88 | 3,984,529.64 |
| 流动资产合计 | 558,702,104.65 | 585,291,429 | 683,078,328.35 | 707,320,893.02 |
| 非流动资产: | | | | |
| 长期股权投资 | 161,155,407.34 | 150,156,668 | 150,157,421.45 | 150,157,987.42 |
| 其他权益工具投资 | 12,657,000 | 12,657,000 | - | - |
| 其他非流动金融资产 | 6,000,000 | 6,000,000 | 6,000,000 | 6,000,000 |
| 固定资产 | 1,191,249,185.89 | 1,208,701,587.7 | 1,239,124,395.63 | 1,257,142,416.62 |
| 在建工程 | 1,292,309.73 | 760,566.37 | 187,610.62 | 187,610.62 |
| 使用权资产 | 60,441,774.03 | 62,806,799.43 | 65,754,524.21 | 68,997,074.57 |
| 无形资产 | 191,833,211.91 | 193,377,246.65 | 196,503,653.65 | 198,811,411.94 |
| 商誉 | 14,751,033.3 | 14,751,033.3 | 35,142,275.12 | 35,142,275.12 |
| 长期待摊费用 | 44,364,097.79 | 45,545,572.48 | 46,405,641.31 | 47,577,489.96 |
| 递延所得税资产 | 24,134,393.81 | 25,301,578.7 | 53,750,308.25 | 46,186,165.71 |
| 其他非流动资产 | 1,848,261.79 | 4,289,291.39 | 19,855,865.38 | 10,378,742.11 |
| 非流动资产合计 | 1,709,726,675.59 | 1,724,347,344.02 | 1,812,881,695.62 | 1,820,581,174.07 |
| 资产总计 | 2,268,428,780.24 | 2,309,638,773.02 | 2,495,960,023.97 | 2,527,902,067.09 |
| 流动负债: | | | | |
| 短期借款 | 452,229,772.9 | 385,233,026.81 | 408,179,616.59 | 409,159,914.36 |
| 应付票据及应付账款 | 114,819,157.29 | 128,491,605.92 | 146,343,653.66 | 149,689,773.62 |
| 其中：应付票据 | 14,119,600 | 20,593,870 | 20,995,720 | 22,030,000 |
| 应付账款 | 100,699,557.29 | 107,897,735.92 | 125,347,933.66 | 127,659,773.62 |
| 预收款项 | 8,562.72 | 11,773.74 | 2,140.68 | 5,351.7 |
| 合同负债 | 55,908,124.43 | 52,153,069.28 | 49,879,731.98 | 50,468,365.13 |
| 应付职工薪酬 | 13,772,973.02 | 19,668,527.08 | 18,125,412.84 | 16,321,119.26 |
| 应交税费 | 5,834,476.18 | 8,490,100.03 | 8,486,180.17 | 5,694,763.63 |
| 其他应付款合计 | 35,181,849.75 | 18,818,206.08 | 18,285,910.29 | 18,441,101.85 |
| 一年内到期的非流动负债 | 30,444,965.59 | 17,725,644.78 | 12,915,527.69 | 13,342,255.8 |
| 其他流动负债 | 4,248,819.71 | 3,824,937.26 | 3,714,493.73 | 3,770,563.02 |
| 流动负债合计 | 712,448,701.59 | 634,416,890.98 | 665,932,667.63 | 666,893,208.37 |
| 非流动负债: | | | | |
| 长期借款 | 233,900,161.96 | 247,725,826.92 | 252,888,067.33 | 252,879,460.1 |
| 租赁负债 | 56,540,231.04 | 56,374,769.75 | 60,773,942.12 | 61,065,555.96 |
| 长期应付款 | 504,410.2 | 594,332.98 | 831,466.57 | 877,891.91 |
| 预计负债 | 59,927,800.89 | 60,113,694.7 | 23,031,158.45 | 26,111,569.55 |
| 递延收益 | 4,401,206.92 | 4,860,878.62 | 4,463,568.99 | 5,829,442.77 |
| 非流动负债合计 | 355,273,811.01 | 369,669,502.97 | 341,988,203.46 | 346,763,920.29 |
| 负债合计 | 1,067,722,512.6 | 1,004,086,393.95 | 1,007,920,871.09 | 1,013,657,128.66 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 525,090,615 | 525,090,615 | 525,090,615 | 525,090,615 |
| 资本公积 | 599,518,440.93 | 599,518,440.93 | 599,518,440.93 | 599,518,440.93 |
| 减:库存股 | 100,090,783.92 | 21,986,838.28 | 12,090,917.77 | 12,090,917.77 |
| 其他综合收益 | 3,047,046.78 | 5,540,938.37 | 6,703,750.12 | 7,259,247.71 |
| 盈余公积 | 37,369,257.89 | 37,369,257.89 | 37,369,257.89 | 37,369,257.89 |
| 未分配利润 | 47,971,860.78 | 73,893,244.8 | 242,325,432 | 266,779,939.27 |
| 归属于母公司股东权益合计 | 1,112,906,437.46 | 1,219,425,658.71 | 1,398,916,578.17 | 1,423,926,583.03 |
| 少数股东权益 | 87,799,830.18 | 86,126,720.36 | 89,122,574.71 | 90,318,355.4 |
| 股东权益合计 | 1,200,706,267.64 | 1,305,552,379.07 | 1,488,039,152.88 | 1,514,244,938.43 |
| 负债和股东权益合计 | 2,268,428,780.24 | 2,309,638,773.02 | 2,495,960,023.97 | 2,527,902,067.09 |
| 公告日期 | 2026-04-30 | 2026-04-30 | 2025-10-31 | 2025-08-21 |
| 审计意见(境内) | | 带强调事项段的无保留意见 | | |